| 1 | Energy | XLE | +50.1% |
| 2 | Technology | XLK | +31.5% |
| 3 | Healthcare | XLV | +16.4% |
| 4 | Consumer Staples | XLP | +11.9% |
| 5 | Materials | XLB | +11.6% |
| 6 | Industrials | XLI | +6.0% |
| 7 | Real Estate | XLRE | +4.0% |
| 8 | Financials | XLF | +2.0% |
| 9 | Utilities | XLU | -1.0% |
| 10 | Consumer Disc. | XLY | -2.9% |
| 11 | Communication | XLC | -12.0% |
Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. …
| Qtr | Date | EPS Est | Act | Δ | YoY | Rev Est | Act | Δ | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Q2 '26 | 8/4/26 | $-1.11 | $-1.18 | -6.3% | -18% | $0.0B | $0.0B | -97.4% | -94% |
| Q1 '26 | 5/7/26 | $-0.98 | $-0.91 | +7.1% | +26% | $0.0B | $0.0B | +1.3% | +325% |
| Q4 '25 | 2/24/26 | $-1.12 | $-0.10 | +91.1% | +91% | $0.0B | $0.1B | +7.4% | +280% |
| Q3 '25 | 11/4/25 | $-1.01 | $-1.10 | -8.9% | +6% | $0.0B | $0.0B | -24.4% | -32% |
| Q2 '25 | 8/5/25 | $-1.07 | $-1.00 | +6.5% | +10% | $0.0B | $0.0B | -37.3% | -28% |
| Q1 '25 | 5/6/25 | $-1.17 | $-1.24 | -6.0% | -2% | $0.0B | $0.0B | -49.1% | +1% |